1. Collagen formation, function and role in kidney disease.
- Author
-
De Gregorio, Vanessa, Barua, Moumita, and Lennon, Rachel
- Subjects
- *
RENAL fibrosis , *POST-translational modification , *PROTEOLYSIS , *CELL communication , *URINARY organs - Abstract
Highly abundant in mammals, collagens define the organization of tissues and participate in cell signalling. Most of the 28 vertebrate collagens, with the exception of collagens VI, VII, XXVI and XXVIII, can be categorized into five subgroups: fibrillar collagens, network-forming collagens, fibril-associated collagens with interrupted triple helices, membrane-associated collagens with interrupted triple helices and multiple triple-helix domains with interruptions. Collagen peptides are synthesized from the ribosome and enter the rough endoplasmic reticulum, where they undergo numerous post-translational modifications. The collagen chains form triple helices that can be secreted to form a diverse array of supramolecular structures in the extracellular matrix. Collagens are ubiquitously expressed and have been linked to a broad spectrum of disorders, including genetic disorders with kidney phenotypes. They also have an important role in kidney fibrosis and mass spectrometry-based proteomic studies have improved understanding of the composition of fibrosis in kidney disease. A wide range of therapeutics are in development for collagen and kidney disorders, including genetic approaches, chaperone therapies, protein degradation strategies and anti-fibrotic therapies. Improved understanding of collagens and their role in disease is needed to facilitate the development of more specific treatments for collagen and kidney disorders. Collagens are ubiquitously expressed and have been linked to a broad spectrum of disorders. Here, the authors discuss collagen subtypes and provide a summary of collagen disorders, fibrotic process and therapies, with an emphasis on kidney diseases. Key points: Collagens are highly abundant in vertebrates and have critical roles in structural integrity, tissue organization and signalling. Collagens undergo a series of processing events that begin with trafficking into the rough endoplasmic reticulum and post-translational modification. Pathogenic variants in collagen genes are associated with a spectrum of disorders. In the kidney, collagen variants cause Alport syndrome, congenital abnormalities of the kidney and urinary tract and the multisystem disorder, Gould syndrome. Dysregulated collagens are also a hallmark of fibrosis, which is a major cause of organ failure. Current and future therapies for collagen disorders and kidney diseases can be broadly categorized as genetic approaches, chaperone therapies, protein degradation strategies and anti-fibrotic therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF